184 related articles for article (PubMed ID: 35955870)
1. diaPASEF Proteomics and Feature Selection for the Description of Sputum Proteome Profiles in a Cohort of Different Subtypes of Lung Cancer Patients and Controls.
Arenas-De Larriva MDS; Fernández-Vega A; Jurado-Gamez B; Ortea I
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955870
[TBL] [Abstract][Full Text] [Related]
2. Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.
Mundt F; Johansson HJ; Forshed J; Arslan S; Metintas M; Dobra K; Lehtiö J; Hjerpe A
Mol Cell Proteomics; 2014 Mar; 13(3):701-15. PubMed ID: 24361865
[TBL] [Abstract][Full Text] [Related]
3. Identification of ENO1 as a potential sputum biomarker for early-stage lung cancer by shotgun proteomics.
Yu L; Shen J; Mannoor K; Guarnera M; Jiang F
Clin Lung Cancer; 2014 Sep; 15(5):372-378.e1. PubMed ID: 24984566
[TBL] [Abstract][Full Text] [Related]
4. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
[TBL] [Abstract][Full Text] [Related]
5. Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer.
Carvalho AS; Cuco CM; Lavareda C; Miguel F; Ventura M; Almeida S; Pinto P; de Abreu TT; Rodrigues LV; Seixas S; Bárbara C; Azkargorta M; Elortza F; Semedo J; Field JK; Mota L; Matthiesen R
Sci Rep; 2017 Feb; 7():42190. PubMed ID: 28169345
[TBL] [Abstract][Full Text] [Related]
6. Using feature selection and Bayesian network identify cancer subtypes based on proteomic data.
Wang Y; Gao X; Ru X; Sun P; Wang J
J Proteomics; 2023 May; 280():104895. PubMed ID: 37024076
[TBL] [Abstract][Full Text] [Related]
7. Proteomic biomarkers for lung cancer progression.
Ren Y; Zhao S; Jiang D; Feng X; Zhang Y; Wei Z; Wang Z; Zhang W; Zhou QF; Li Y; Hou H; Xu Y; Zhou F
Biomark Med; 2018 Mar; 12(3):205-215. PubMed ID: 29424557
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today?
D'Amato M; Iadarola P; Viglio S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628501
[TBL] [Abstract][Full Text] [Related]
9. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.
Planque C; Kulasingam V; Smith CR; Reckamp K; Goodglick L; Diamandis EP
Mol Cell Proteomics; 2009 Dec; 8(12):2746-58. PubMed ID: 19776420
[TBL] [Abstract][Full Text] [Related]
10. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
[TBL] [Abstract][Full Text] [Related]
11. DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.
Hubers AJ; Heideman DA; Duin S; Witte BI; de Koning HJ; Groen HJ; Prinsen CF; Bolijn AS; Wouters M; van der Meer SE; Steenbergen RD; Snijders PJ; Uyterlinde A; Berkhof H; Smit EF; Thunnissen E
J Clin Pathol; 2017 Mar; 70(3):250-254. PubMed ID: 27496969
[TBL] [Abstract][Full Text] [Related]
12. Application of proteomics in non-small-cell lung cancer.
Cho WC
Expert Rev Proteomics; 2016; 13(1):1-4. PubMed ID: 26577456
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
[TBL] [Abstract][Full Text] [Related]
15. Molecular sputum analysis for the diagnosis of lung cancer.
Hubers AJ; Prinsen CF; Sozzi G; Witte BI; Thunnissen E
Br J Cancer; 2013 Aug; 109(3):530-7. PubMed ID: 23868001
[TBL] [Abstract][Full Text] [Related]
16. Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases.
Terracciano R; Preianò M; Palladino GP; Carpagnano GE; Barbaro MP; Pelaia G; Savino R; Maselli R
Proteomics; 2011 Aug; 11(16):3402-14. PubMed ID: 21751363
[TBL] [Abstract][Full Text] [Related]
17. A gas phase fractionation acquisition scheme integrating ion mobility for rapid diaPASEF library generation.
Penny J; Arefian M; Schroeder GN; Bengoechea JA; Collins BC
Proteomics; 2023 Apr; 23(7-8):e2200038. PubMed ID: 36876969
[TBL] [Abstract][Full Text] [Related]
18. Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome.
Burg D; Schofield JPR; Brandsma J; Staykova D; Folisi C; Bansal A; Nicholas B; Xian Y; Rowe A; Corfield J; Wilson S; Ward J; Lutter R; Fleming L; Shaw DE; Bakke PS; Caruso M; Dahlen SE; Fowler SJ; Hashimoto S; Horváth I; Howarth P; Krug N; Montuschi P; Sanak M; Sandström T; Singer F; Sun K; Pandis I; Auffray C; Sousa AR; Adcock IM; Chung KF; Sterk PJ; Djukanović R; Skipp PJ; The U-Biopred Study Group
J Proteome Res; 2018 Jun; 17(6):2072-2091. PubMed ID: 29737851
[TBL] [Abstract][Full Text] [Related]
19. Proteomics-based identification of tumor relevant proteins in lung adenocarcinoma.
Zhou X; Xue L; Hao L; Liu S; Zhou F; Xiong H; Qi X; Lin D; Shao S
Biomed Pharmacother; 2013 Sep; 67(7):621-7. PubMed ID: 23916545
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
